Karl E Anderson
Overview
Explore the profile of Karl E Anderson including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
91
Citations
1956
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Roach A, Barkley H, Rodriquez C, Burrow T, Anderson K, Shukla A
Eur J Hum Genet
. 2025 Mar;
PMID: 40065013
No abstract available.
2.
Levy C, Naik H, Overbey J, Hedstrom K, Wang K, McDonough C, et al.
Hepatol Commun
. 2025 Feb;
9(3).
PMID: 39969427
Background: Erythropoietic protoporphyria (EPP) and X-linked protoporphyria (XLP) are characterized by the accumulation of protoporphyrin in the marrow, erythrocytes, plasma, skin, and liver, and present clinically with painful cutaneous phototoxicity....
3.
Ramanujam V, Moghe A, Huda R, Turner S, Anderson K
Curr Protoc
. 2025 Feb;
5(2):e70092.
PMID: 39927625
Porphyrins and porphyrin precursors are normally detected in small amounts in healthy individuals but are found in large quantities in the urine, feces, blood, plasma, bone marrow, and liver in...
4.
Roach A, Barkley H, Rodriquez C, Burrow T, Anderson K, Shukla A
Eur J Hum Genet
. 2024 Dec;
PMID: 39663403
δ-Aminolevulinic acid (ALA) dehydratase (ALAD) deficient porphyria (ADP) is an extremely rare form of porphyria, with only eight documented cases. Herein, we report the second known case of ADP in...
5.
Zhu J, Qin F, Lei S, Gu R, Qi Q, Lu J, et al.
Nat Commun
. 2024 Dec;
15(1):10557.
PMID: 39632884
Erythropoietic protoporphyria (EPP) is a genetic disease characterized by protoporphyrin IX-mediated painful phototoxicity. Currently, options for the management of EPP-associated phototoxicity are limited and no oral medication is available. Here,...
6.
Singal A, Reddy R, Gudiwada M, Jasti J, Anderson K
Dig Dis Sci
. 2024 Oct;
69(11):4268-4274.
PMID: 39438413
Background And Aims: Hepatocellular carcinoma (HCC) is a long-term complication of acute hepatic porphyria (AHP) inclusive of acute intermittent porphyria [AIP], variegate porphyria [VP], or hereditary coproporphyria [HCP]. Data on...
7.
Sardh E, Balwani M, Rees D, Anderson K, Jia G, Sweetser M, et al.
Orphanet J Rare Dis
. 2024 Oct;
19(1):365.
PMID: 39363243
Background: Acute hepatic porphyria is a group of multisystem disorders of which acute intermittent porphyria is the most common subtype. Givosiran, a subcutaneously administered RNA interference therapeutic targeting liver ALAS...
8.
Leaf R, Naik H, Jiang P, Elmariah S, Hodges P, Mead J, et al.
Life (Basel)
. 2024 Jun;
14(6).
PMID: 38929673
Background: Erythropoietic protoporphyria (EPP) and X-linked protoporphyria (XLP) are rare disorders of heme biosynthesis characterized by severe cutaneous phototoxicity. Afamelanotide, an α-melanocyte-stimulating hormone analogue, is the only approved treatment for...
9.
Jerico D, Cordoba K, Urigo F, Enriquez de Salamanca R, Anderson K, Deybach J, et al.
Liver Int
. 2024 May;
44(9):2174-2190.
PMID: 38813953
Porphyrias are rare, mostly inherited disorders resulting from altered activity of specific enzymes in the haem synthesis pathway that lead to accumulation of pathway intermediates. Photocutaneous symptoms occur when excess...
10.
Badminton M, Anderson K, Deybach J, Harper P, Sandberg S, Elder G
Liver Int
. 2024 May;
44(9):2144-2155.
PMID: 38767598
We describe developments in understanding of the porphyrias associated with each step in the haem biosynthesis pathway and the role of individuals whose contributions led to major advances over the...